Radioactive nanoparticles and methods of making and using the same
In one aspect, radioactive nanoparticles are described herein. In some embodiments, a radioactive nanoparticle described herein comprises a metal nanoparticle core, an outer metal shell disposed over the metal nanoparticle core, and a metallic radioisotope disposed within the metal nanoparticle core or within the outer metal shell. In some cases, the radioactive nanoparticle has a size of about 30-500 nm in three dimensions. In addition, in some embodiments, the radioactive nanoparticle further comprises an inner metal shell disposed between the metal nanoparticle core and the outer metal shell. The metal nanoparticle core, outer metal shell, and inner metal shell of the radioactive nanoparticle can have various metallic compositions.
1. A radioactive nanoparticle comprising:
a metal nanoparticle core;
an outer metal shell disposed over the metal nanoparticle core;
a metallic radioisotope disposed within the metal nanoparticle core or within the outer metal shell; and
an inner metal shell disposed between the metal nanoparticle core and the outer metal shell,
wherein the radioactive nanoparticle has a size of about 30-500 nm in three dimensions,
wherein the metal nanoparticle core is formed from Au, the inner metal shell is formed from Cu, and the outer metal shell is formed from Pd, Rh, or Au, and
wherein radiation emitted by the metallic radioisotope passes through the inner metal shell and/or the outer metal shell into a surrounding environment of the nanoparticle without heating the inner metal shell and/or the outer metal shell.
2. The radioactive nanoparticle of claim 1 , wherein the radioactive nanoparticle has a size of about 80-200 nm in three dimensions.
3. The radioactive nanoparticle of claim 1 , wherein the metal nanoparticle core and the outer metal shell are formed from the same metal or combination of metals.
4. The radioactive nanoparticle of claim 1 , wherein the metallic radioisotope is disposed within the outer metal shell.
5. The radioactive nanoparticle of claim 4 , wherein the metallic radioisotope comprises a metal that is the same as a metal of the outer metal shell.
6. The radioactive nanoparticle of claim 4 , wherein the metallic radioisotope and the outer metal shell are formed from differing metallic elements.
7. The radioactive nanoparticle of claim 1 further comprising a second metallic radioisotope disposed within the metal nanoparticle core or within the outer metal shell.
8. The radioactive nanoparticle of claim 1 , wherein the metallic radioisotope is disposed within the metal nanoparticle core.
9. The radioactive nanoparticle of claim 1 , wherein the metallic radioisotope comprises Cu-64, Cu-67, Y-90, Pd-103, Rh-105, Re-186, Re-188, Ir-192, or Au-198.
10. The radioactive nanoparticle of claim 1 , wherein the radioactive nanoparticle has a negative surface charge.
11. A method of performing brachytherapy, the method comprising:
disposing a composition within a biological compartment,
wherein the composition comprises a plurality of radioactive nanoparticles, at least one of the plurality of radioactive nanoparticles comprising:
a metal nanoparticle core;
an outer metal shell disposed over the metal nanoparticle core;
a metallic radioisotope disposed within the metal nanoparticle core or within the outer metal shell; and
an inner metal shell disposed between the metal nanoparticle core and the outer metal shell,
wherein the radioactive nanoparticle has a size of about 30-500 nm in three dimensions,
wherein the metal nanoparticle core is formed from Au, the inner metal shell is formed from Cu, and the outer metal shell is formed from Pd, Rh, or Au, and
wherein radiation emitted by the metallic radioisotope passes through the inner metal shell and/or the outer metal shell into a surrounding environment of the nanoparticle without heating the inner metal shell and/or the outer metal shell.
12. The method of claim 11 , wherein the metallic radioisotope is aβ-emitter.
13. The method of claim 11 , wherein the biological compartment is a tumor.
14. The method of claim 13 , wherein at least about 80% of the radioactive nanoparticles are retained within the tumor for at least 3 weeks.
15. The method of claim 11 further comprising:
irradiating the biological compartment with an external beam of ionizing radiation.
16. The radioactive nanoparticle of claim 1 , wherein the metallic radioisotope is a β-emitter.
17. The radioactive nanoparticle of claim 1 , wherein the radioactive nanoparticle has a radioactivity of about 0.4 to 400 Bq.